Xiaofeng Zhou | Director of Epidemiology
Pfizer

Xiaofeng Zhou, Director of Epidemiology, Pfizer

Dr. Xiaofeng Zhou is a director in World Safety Strategy’s Epidemiology group at Pfizer Inc. She has 16 years of working experience with Pfizer in a wide variety of roles including the clinical development operation, post marketing drug safety and pharmacovigilance, clinical safety and risk management, and epidemiology. She has published and presented on signal detection methods, safety and epidemiological studies, and common data model evaluations etc. Xiaofeng has multiple responsibilities in the design and conduct of Epidemiological studies and, in addition, has led Pfizer’s successful implementation of the OMOP Common Data Model and ensured that lessons learnt are incorporated into active surveillance strategies moving forwards. She earned her doctoral degree in Epidemiology from University of Michigan and holds Masters Degrees in Statistics and Applied Economics from Virginia Tech, and Food and Nutrition Planning from University of Philippines.

Share this

Appearances at this years' conference:

Day Two Thursday 22 March 2012


@ 14.10
Challenges and opportunities in Active Surveillance and lessons learnt as a member of the OMOP Extended Consortium

• Discuss the key concepts of active surveillance and the potential prospects for wide spread use
• Present an overview of OMOP activities and its value for active surveillance activities at a large pharmaceutical company
• Introduce and discuss other initiatives in the field of active surveillance

  • › Xiaofeng Zhou, Director of Epidemiology, Pfizer
Sponsors
Session Facilitators
PRA International at Late Phase Drug Development World Americas 2012
Session presentation sponsor
Medidata Solutions Inc at Late Phase Drug Development World Americas 2012
Session presentation sponsor
OptumInsight at Late Phase Drug Development World Americas 2012
Session presentation sponsor
Oracle Corporation UK Limited at Late Phase Drug Development World Americas 2012
Session presentation sponsor
CRF Health at Late Phase Drug Development World Americas 2012
Session presentation sponsor
PharmaNet/i3 at Late Phase Drug Development World Americas 2012
Session presentation sponsor
United BioSource Corporation at Late Phase Drug Development World Americas 2012